Literature DB >> 15131351

The dog genome map and its use in mammalian comparative genomics.

Marek Switonski1, Izabela Szczerbal, Joanna Nowacka.   

Abstract

The dog genome organization was extensively studied in the last ten years. The most important achievements are the well-developed marker genome maps, including over 3200 marker loci, and a survey of the DNA genome sequence. This knowledge, along with the most advanced map of the human genome, turned out to be very useful in comparative genomic studies. On the one hand, it has promoted the development of marker genome maps of other species of the family Canidae (red fox, arctic fox, Chinese raccoon dog) as well as studies on the evolution of their karyotype. But the most important approach is the comparative analysis of human and canine hereditary diseases. At present, causative gene mutations are known for 30 canine hereditary diseases. A majority of them have human counterparts with similar clinical and molecular features. Studies on identification of genes having a major impact on some multifactorial diseases (hip dysplasia, epilepsy) and cancers (multifocal renal cystadenocarcinoma and nodular dermatofibrosis) are advanced. Very promising are the results of gene therapy for certain canine monogenic diseases (haemophilia, hereditary retinal dystrophy, mucopolysaccharidosis), which have human equivalents. The above-mentioned examples prove a very important model role of the dog in studies of human genetic diseases. On the other hand, the identification of gene mutations responsible for hereditary diseases has a substantial impact on breeding strategy in the dog.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15131351

Source DB:  PubMed          Journal:  J Appl Genet        ISSN: 1234-1983            Impact factor:   3.240


  7 in total

Review 1.  The function of dog models in developing gene therapy strategies for human health.

Authors:  Keri L Nowend; Alison N Starr-Moss; Keith E Murphy
Journal:  Mamm Genome       Date:  2011-07-06       Impact factor: 2.957

Review 2.  Substrate deprivation therapy: a new hope for patients suffering from neuronopathic forms of inherited lysosomal storage diseases.

Authors:  Joanna Jakóbkiewicz-Banecka; Alicja Wegrzyn; Grzegorz Wegrzyn
Journal:  J Appl Genet       Date:  2007       Impact factor: 3.240

Review 3.  Pharmacogenetic and metabolic differences between dog breeds: their impact on canine medicine and the use of the dog as a preclinical animal model.

Authors:  Steven Fleischer; Michele Sharkey; Katrina Mealey; Elaine A Ostrander; Marilyn Martinez
Journal:  AAPS J       Date:  2008-02-15       Impact factor: 4.009

Review 4.  Heat shock proteins in animal neoplasms and human tumours--a comparison.

Authors:  Mariarita Romanucci; Tania Bastow; Leonardo Della Salda
Journal:  Cell Stress Chaperones       Date:  2008-03-12       Impact factor: 3.667

Review 5.  Canine genomics and genetics: running with the pack.

Authors:  Heidi G Parker; Elaine A Ostrander
Journal:  PLoS Genet       Date:  2005-11       Impact factor: 5.917

Review 6.  Inheritance of Monogenic Hereditary Skin Disease and Related Canine Breeds.

Authors:  Pablo Jesús Marín-García; Lola Llobat
Journal:  Vet Sci       Date:  2022-08-15

Review 7.  Impact of gene therapy for canine monogenic diseases on the progress of preclinical studies.

Authors:  Marek Switonski
Journal:  J Appl Genet       Date:  2020-03-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.